Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1

被引:2
|
作者
Asadollahi, Kazem [1 ,2 ,3 ]
Rajput, Sunnia [2 ]
de Zhang, Lazarus Andrew [3 ,4 ]
Ang, Ching-Seng [2 ]
Nie, Shuai [2 ]
Williamson, Nicholas A. [2 ]
Griffin, Michael D. W. [1 ,2 ]
Bathgate, Ross A. D. [1 ,3 ]
Scott, Daniel J. [1 ,3 ]
Weikl, Thomas R. [5 ]
Jameson, Guy N. L. [2 ,6 ]
Gooley, Paul R. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Biochem & Pharmacol, Parkville, Vic 3010, Australia
[2] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia
[3] Univ Melbourne, The Florey, Parkville, Vic 3010, Australia
[4] Monash Univ, Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia
[5] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, D-14476 Potsdam, Germany
[6] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
PROTEIN-COUPLED RECEPTOR; CONFORMATIONAL SELECTION; ALLOSTERIC MODULATOR; MASS-SPECTROMETRY; LIGAND EFFICACY; F-19; NMR; BINDING; ACTIVATION; SITE; EVOLUTION;
D O I
10.1038/s41467-023-44010-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The conformational ensembles of G protein-coupled receptors (GPCRs) include inactive and active states. Spectroscopy techniques, including NMR, show that agonists, antagonists and other ligands shift the ensemble toward specific states depending on the pharmacological efficacy of the ligand. How receptors recognize ligands and the kinetic mechanism underlying this population shift is poorly understood. Here, we investigate the kinetic mechanism of neurotensin recognition by neurotensin receptor 1 (NTS1) using 19F-NMR, hydrogen-deuterium exchange mass spectrometry and stopped-flow fluorescence spectroscopy. Our results indicate slow-exchanging conformational heterogeneity on the extracellular surface of ligand-bound NTS1. Numerical analysis of the kinetic data of neurotensin binding to NTS1 shows that ligand recognition follows an induced-fit mechanism, in which conformational changes occur after neurotensin binding. This approach is applicable to other GPCRs to provide insight into the kinetic regulation of ligand recognition by GPCRs. GPCRs include inactive and active states. 19F-NMR and stopped-flow fluorescence kinetic assays reveal that neurotensin activates the prototypical peptide-binding GPCR, neurotensin receptor 1, through an induced-fit mechanism, where ligand binding precedes receptor conformational changes.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Structure of the neurotensin receptor 1 in complex with β-arrestin 1
    Weijiao Huang
    Matthieu Masureel
    Qianhui Qu
    John Janetzko
    Asuka Inoue
    Hideaki E. Kato
    Michael J. Robertson
    Khanh C. Nguyen
    Jeffrey S. Glenn
    Georgios Skiniotis
    Brian K. Kobilka
    Nature, 2020, 579 : 303 - 308
  • [22] Encounter Complexes Between the N-terminal of Neurotensin with the Extracellular Loop 2 of the Neurotensin Receptor 1 Steer Neurotensin to the Orthosteric Binding Pocket
    Asadollahi, Kazem
    Rajput, Sunnia
    Jameson, Guy N. L.
    Scott, Daniel J.
    Gooley, Paul R.
    JOURNAL OF MOLECULAR BIOLOGY, 2023, 435 (20)
  • [23] MAST-CELL BINDING OF NEUROTENSIN .1. IODINATION OF NEUROTENSIN AND CHARACTERIZATION OF INTERACTION OF NEUROTENSIN WITH MAST-CELL RECEPTOR-SITES
    LAZARUS, LH
    PERRIN, MH
    BROWN, MR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1977, 252 (20) : 7174 - 7179
  • [24] Discovery of Highly Potent and Neurotensin Receptor 2 Selective Neurotensin Mimetics
    Einsiedel, Juergen
    Held, Cornelia
    Hervet, Maud
    Plomer, Manuel
    Tschammer, Nuska
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (08) : 2915 - 2923
  • [25] Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception
    Tyler, BM
    Cusack, B
    Douglas, CL
    Souder, T
    Richelson, E
    BRAIN RESEARCH, 1998, 792 (02) : 246 - 252
  • [26] Neurotensin and neurotensin receptors
    Vincent, JP
    Mazella, J
    Kitabgi, P
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (07) : 302 - 309
  • [27] Evaluation of DOTA-chelated neurotensin analogs with a spacer for targeting of neurotensin receptor 1 positive tumors
    Jia, Yinnong
    Shi, Wen
    Zhou, Zhengyuan
    Wagh, Nilesh
    Brusnahan, Susan
    Garrison, Jered
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [28] Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1
    Falciani, C.
    Brunetti, J.
    Lelli, B.
    Ravenni, N.
    Lozzi, L.
    Depau, L.
    Pini, A.
    Bracci, L.
    JOURNAL OF PEPTIDE SCIENCE, 2012, 18 : S46 - S46
  • [29] Neurotensin effect on central muscarinic receptors is independent of high affinity neurotensin receptor (NTS1)
    Schneider, PG
    Ordieres, MGL
    Kokubu, BAO
    Magliarella, P
    Arnaiz, GRD
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 59 - 59
  • [30] Sensorimotor Gating of Neurotensin-1 Receptor and Neurotensin-2 Receptor Null Mice: Neurotensin-1 Receptor is Essential for d -Amphetamine and Dizocilpine Induced Disruption of Pre-Pulse Inhibition
    Oliveros, Alfredo
    Heckman, Michael G.
    Williams, Katrina
    Boules, Mona
    Richelson, Elliott
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 265S - 265S